pillbase.ru

Byfavo

Active substance: remimazolam

remimazolam besilate

Centralised EU authorisationActive

Marketing holder: Paion Pharma GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • BYFAVO
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · REMIMAZOLAM BESYLATE 2.5 mg/mL
    71390-011
    Acacia Pharma, Ltd.
Import and control

Control by country

  • United StatescontrolledSchedule: CIV

    Source: openFDA NDC · record 01a12097-2e45-7638-ba1b-a9460aa05998;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005246
Registration status
Active
ATC code
N05CD14
Sources
  • product · EMA · EMEA/H/C/005246 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005246 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005246 · Verified 2026-10-09